Tech Comm Available Technologies :: The Research Institute at Nationwide Children's Hospital, Columbus, Ohio

Details

Project TitleNovel screening assay to identify and evaluate drugs that target Familial and Sporadic Amyotrophic Lateral Scelrosis
Track Code2011-016
Websitehttp://www.nationwidechildrens.org/technology-commercialization
Short Description

 In vitro cell-based assay that enables investigating molecular disease mechanisms and evaluating potential therapies for Sporadic Amyotrophic Lateral Sclerosis (ALS).

Abstract

This is an in vitro cell-based assay that enables investigating molecular disease mechanisms and evaluating potential therapies for Sporadic Amyotrophic Lateral Sclerosis (ALS). This assay utilizes human derived cells from individuals with the disease.

 
Tagsresearch tool, als
 
Posted DateJan 24, 2014 12:59 PM

Researcher

Name
Brian Kaspar

Manager

Name
Margaret Barkett

Inquiry

Margaret Barkett, Ph.D.

The Research Institute at Nationwide Children's Hospital

Office of Technology Commercialization

700 Children's Drive

Columbus OH 43205

T: 614 355-2957    F: 614 722-2716

Margaret.Barkett@nationwidechildrens.org

Intellectual Property

Patent Number Issue Date Type Country of Filing
None None Other Patent None
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000